A randomized double-blind placebo-controlled trial of a Chinese herbal medicine preparation (Jiawei Qing'e Fang) for hot flashes and quality of life in perimenopausal women

Menopause

Volumn 19, Issue 2, 2012, Pages 234-244

  Xia, Ye ^a   Zhao, Yingqiang ^a   Ren, Ming ^a   Zhang, Junhua ^a   Wang, Yuefei ^a   Chang, Yanxu ^a   Fu, Shufei ^a   Fan, Guanwei ^a   Zhu, Yan ^a   Huang, Yuhong ^a   Gao, Xiumei ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Chinese herbal medicine; Hot flash; Menopause

Indexed keywords

CHINESE DRUG; CORTEX EUCOMMIAE EXTRACT; ESTRADIOL; FOLLITROPIN; FRUCTUS PSORALEAE EXTRACT; JIAWEI QINGE FANG EXTRACT; PLACEBO; PLANT EXTRACT; SALVIAE MILTIORRHIZAE EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; CORTEX EUCOMMIAE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FRUCTUS PSORALEAE; HOT FLUSH; HUMAN; HYDROSALPINX; JIAWEI QINGE FANG; MAJOR CLINICAL STUDY; MEDICINAL PLANT; MENOPAUSAL SYNDROME; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SALVIAE MILTIORRHIZAE; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; VASOMOTOR REFLEX;

DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; PERIMENOPAUSE; PHYTOTHERAPY; PLACEBOS; QUALITY OF LIFE; TRIGLYCERIDES;

EID: 84863011238     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3182273177     Document Type: Article

References (45)

1. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-473.
2. The North American Menopause Society. Treatment of menopauseassociated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11:11-33.
3. Million Women Study Collaborators. Breast cancer and hormonereplacement therapy in the Million Women Study. Lancet 2003;362: 419-427.
4. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003;289:3243-3253. (Pubitemid 37430077)
5. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003;289:2673-2684. (Pubitemid 37430138)
6. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291:1701-1712. (Pubitemid 38489892)
7. Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
8. Gold EB, Bair Y, Zhang GL, et al. Cross-sectional analysis of specific complementary and alternative medicine (CAM) use by racial/ethnic group and menopausal status: the Study of Women's Health Across the Nation (SWAN). Menopause 2007;14:612-623. (Pubitemid 47051953)
9. Davis SR, Briganti EM, Chen RQ, et al. The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women. A randomised controlled trial. Med J Aust 2001;174:68-71. (Pubitemid 32094129)
10. Van der Sluijs CP, Bensoussan A, Chang S, et al. A randomized placebocontrolled trial on the effectiveness of an herbal formula to alleviate menopausal vasomotor symptoms. Menopause 2009;16:336-344.
11. Haines CJ, Lam PM, Chung TK, et al. A randomized, double-blind, placebo-controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climacteric 2008;11:244-251.
12. Grady D, Sawaya GF, Johnson KC, et al. MF101, a selective estrogen receptor A-modulator for the treatment of menopausal hot flashes: a phase II clinical trial. Menopause 2009;16:1-8.
13. Kwee SH, Tan HH, Marsman A, et al. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to Hormone Replacement Therapy (HRT) and placebo. Maturitas 2007;58:83-90. (Pubitemid 47277493)
14. Xu Y, Zhang ZJ, Geng F, et al. Treatment with Qing'E, a kidneyinvigorating Chinese herbal formula, antagonizes the estrogen decline in ovariectomized mice. Rejuvenation Res 2010;13:479-488.
15. Xin D, Wang H, Yang J, et al. Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity. Phytomedicine 2010;17: 126-131.
16. Zhang R, Liu ZG, Li C, et al. Du-Zhong (Eucommia ulmoidesVOliv.) cortex extract prevent OVX-induced osteoporosis in rats. Bone 2009; 45:553-559.
17. Fan GW, Gao XM, Wang H, et al. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS. J Steroid Biochem 2009; 113:275-280.
18. Bastian LA, Smith CM, Nanda K. Is this woman perimenopausal? JAMA 2003;289:895-902. (Pubitemid 37430350)
19. Brambilla DJ, McKinlay SM, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol 1994; 140:1091-1095.
20. Hilditch JR, Lewis J, Peter A, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24:161-175.
21. Sloan JA, Loprinzi CL, Novotny PJ, et al. Methodologic lessons learned from hot flash studies. J Clin Oncol 2001;19:4280-4290. (Pubitemid 33096775)
22. Yen GC, Hsieh CL. Antioxidant activity of extracts from Du-zhong (Eucommia ulmoides) toward various lipid peroxidation models in vitro. J Agric Food Chem 1998;46:3952-3957.
23. Fan GW, Zhu Y, Guo H, et al. Direct vasorelaxation by a novel phytoestrogen tanshinone IIA is mediated by nongenomic action of estrogen receptor through endothelial nitric oxide synthase activation and calcium mobilization. J Cardiovasc Pharmacol 2011;57:340-347.
24. Mao HP, Zhang H, Wang H, et al. Dual effects of lipophilic extract of Salvia miltiorrhiza (Danshen) on catecholamine secretion in cultured bovine adrenal medullary cells. J Ethnipharmacol 2009;125:59-67.
25. Simon JA, Stevens RE, Ayres SA, et al. Perimenopausal women in estrogen vasomotor trials: contribution to placebo effect and efficacy outcome. Climacteric 2001;4:19-27. (Pubitemid 32448484)
26. The North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010;17:242-255.
27. van der Sluijs CP, Bensoussan A, Liyanage L, et al. Women's health during mid-life survey: the use of complementary and alternative medicine by symptomatic women transitioning through menopause in Sydney. Menopause 2007;14:397-403.
28. Coon JT, Pittler MH, Ernst E. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and metaanalysis. Phytomedicine 2007;14:153-159. (Pubitemid 46136954)
29. Tice JA, Ettinger B, Ensrud K, et al. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA 2003;290:207-214. (Pubitemid 37430059)
30. Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharm Res 2008; 58:8-14.
31. Osmers R, Friede M, Liske E, et al. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005; 105:1074-1083. (Pubitemid 40571028)
32. Stoll W. Phytopharmacon influence atrophic vaginal epithelium: doubleblind study of Cimicifuga vs. estrogenic substances. Therapeutikon 1987; 1:23-31.
33. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 versus conjugated estrogens in a double-blind placebocontrolled study: effects on menopause symptoms and bone markers. Maturitas 2003;44:S67-S77. (Pubitemid 36263037)
34. Frei-Kleiner S, Schaffner W, Rahlfs V, et al. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebocontrolled clinical trial. Maturitas 2005;51:397-404. (Pubitemid 41019367)
35. Liske E, Hanggi W, Henneicke-von Zepelin HH, et al. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 2002;11:163-174.
36. Newton K, Reed S, LaCroix A, et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006;145:869-879. (Pubitemid 351639962)
37. Huntley AL, Ernst E. Soy for the treatment of perimenopausal symptomsV a systematic review. Maturitas 2004;47:1-9. (Pubitemid 38050010)
38. Geller SE, Shulman LP, van Breemen RB, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009;16:1156-1166.
39. Reed SD, Newton KM, LaCroix AZ, et al. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause 2008;15:51-58.
40. Deng XP, Xu M. The study of hepatoxicity of Psoralea corylifolia and its compound in rats. Guang Xi Zhong Yi Yao 2005;28:49-50.
41. Tan P, Zhao C, Zhou K, et al. The study of hepatoxicity in rats after administration of Psoralea corylifolia for 30 days. Xin Jiang Zhong Yi Yao 2010;28:11-13.
42. Nam SW, Baek JT, Lee DS, et al. A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee). Clin Toxicol 2005;43:589-591. (Pubitemid 41446741)
43. Cheung WI, Tse ML, Ngan T, et al. Liver injury associated with the use of Fructus psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine. Clin Toxicol 2009;47:683-685.
44. Wang YF, Wu B, Yang J, et al. A rapid method for the analysis of ten compounds in Psoralea corylifolia L. by UPLC. Chromatographia 2009;70: 199-204.
45. Chang YX, Ding XP, Qi J, et al. The antioxidant-activity-integrated fingerprint: an advantageous tool for the evaluation of quality of herbal medicines. J Chromatogr A 2008;1208:76-82.